Colorectal Cancer

Colorectal cancer develops in the lining of the colon or rectum. It is one of the most frequently diagnosed cancers in East and Southeast Asia, with notably high rates in Japan, South Korea, Singapore, and Hong Kong, where dietary and lifestyle shifts over recent decades have contributed to rising incidence.

Medicine used to treat Colorectal Cancer

Capnat

Capecitabine

500mg

Developed to target cancerous growths by utilizing systemic conversion to therapeutic agents that inhibit DNA synthesis.

From $2.98 / tablet View

How colorectal cancer is managed

Treatment depends on how far the cancer has spread. Surgery to remove the tumour is usually central to early-stage care. Chemotherapy is added before surgery to shrink a tumour, after surgery to reduce the risk of return, or as the main treatment when the cancer has spread.

Oral chemotherapy is a common part of many regimens. Capecitabine is one of the most widely used agents; the body converts it into fluorouracil at the tumour site, which limits damage to healthy tissue compared with intravenous alternatives. It is often used alongside other medicines or radiotherapy as part of oncology support care.

Any new or persistent change in bowel habits, blood in the stool, unexplained weight loss, or ongoing abdominal discomfort warrants prompt medical assessment.